The dorsal horn is the posterior grey matter region of the spinal cord where peripheral sensory information—particularly nociception, temperature, and touch—first synapses with the central nervous system. Organized into six laminae (Rexed laminae I-VI), it functions as both a relay station and a critical processing center where pain signals are amplified, filtered, or suppressed before ascending to the brain. The dorsal horn is the anatomical substrate for gate control, central sensitization, and descending pain modulation.
Think of the dorsal horn as the security checkpoint at an embassy gate. Every visitor (sensory signal) from the outside world arrives at this checkpoint, but whether they get through—and how much of a fuss they make—depends on three things: the visitor's credentials (C-fibres vs. A-beta fibres), the mood of the guards (local interneurons and their GABA/glycine supply), and orders from headquarters upstairs (descending inhibition from the brainstem). Normally, innocuous visitors (touch, pressure) are waved through quietly. Urgent threats (tissue damage) get escalated immediately. But if the guards are sleep-deprived (loss of inhibitory interneurons), jittery from past trauma (microglial activation), or getting conflicting orders from above (loss of descending modulation), they might sound the alarm for everyone—even the mailman. That's allodynia: the checkpoint is so sensitized that a light touch gets treated like an invasion. And once the alarm system is stuck in "red alert," it stays that way even after the original threat is gone—that's central sensitization, and it's why chronic pain persists long after tissue healing.
Primary sensory neurons enter the spinal cord via the dorsal root and synapse in specific laminae based on fiber type:
- C-fibres (unmyelinated, slow nociceptors) and A-delta fibres (myelinated, fast nociceptors) → Laminae I-II (substantia gelatinosa)
- A-beta fibres (mechanoreceptors) → Laminae III-IV
- Second-order neurons in laminae I and V project across the midline and ascend via:
- Spinothalamic tract → lateral thalamus → somatosensory cortex (discriminative pain)
- Spinoreticular tract → brainstem reticular formation → medial thalamus → anterior cingulate cortex (affective pain)
- Spinomesencephalic tract → periaqueductal gray → descending modulation
Gate Control Mechanism (Melzack & Wall):
- A-beta fibre activation → excites inhibitory interneurons in lamina II → these release GABA and glycine → presynaptic inhibition of C-fibre terminals → reduces Substance P and glutamate release → "closes the gate"
- C-fibre activation → releases Substance P and glutamate → excites second-order projection neurons in lamina I → "opens the gate"
Descending Modulation:
- Periaqueductal gray (PAG) → rostral ventromedial medulla (RVM) → dorsolateral funiculus → dorsal horn laminae I-II
- Descending serotonin (5-HT) and noradrenaline (NA) → activate enkephalin interneurons → μ-opioid receptor activation on C-fibre terminals → inhibits presynaptic Substance P release
- Net effect: descending inhibition suppresses pain transmission
Sensitization Cascade:
- Peripheral inflammation → C-fibre barrage → sustained glutamate and Substance P release
- Glutamate binds NMDA receptors → Ca²⁺ influx → PKC activation → NMDA receptor phosphorylation → "wind-up" (temporal summation)
- Substance P binds NK1 receptors → activates second-order neurons → c-Fos expression (marker of neuronal activation)
- Microglial activation (via P2X4, TLR4) → release BDNF, IL-1β, TNF-α → further excites dorsal horn neurons and downregulates KCC2 (chloride transporter) → impairs GABA/glycine inhibition
- Loss of inhibitory interneurons (apoptosis via caspase-3) → disinhibition → allodynia
graph TD
A[Peripheral Tissue Damage] --> B[C-fibre Activation]
B --> C[Dorsal Horn Laminae I-II]
C --> D["Glutamate + Substance P Release"]
D --> E[NMDA Receptor Activation]
D --> F[NK1 Receptor Activation]
E --> G["Ca²⁺ Influx → Wind-Up"]
F --> H[c-Fos Expression]
G --> I[Central Sensitization]
H --> I
C --> J[Microglial Activation]
J --> K["BDNF, IL-1β, TNF-α Release"]
K --> L[KCC2 Downregulation]
L --> M[GABA Disinhibition]
M --> I
N[Descending Inhibition PAG-RVM] --> O[5-HT, NA Release]
O --> P[Enkephalin Interneurons]
P --> Q["μ-Opioid Receptor Activation"]
Q --> R[Inhibits Substance P Release]
R --> S[Closes Pain Gate]
I --> T[Loss of Descending Inhibition]
T --> U[Chronic Pain State]
The dorsal horn is where acute pain becomes chronic. This is the anatomical site of central sensitization—the pathological amplification of nociceptive signaling that defines conditions like fibromyalgia, chronic low back pain, and complex regional pain syndrome. Understanding dorsal horn processing is essential for pain neuroscience education: patients need to grasp that persistent pain does not equal ongoing tissue damage; it reflects a hyperexcitable dorsal horn stuck in "threat mode."
Metamodel Connections:
- Metamodel 3 (Inflammation): Peripheral inflammation (TNF-α, IL-1β) drives dorsal horn sensitization via microglial activation and NMDA receptor upregulation. The dorsal horn integrates systemic inflammatory signals with local nociceptive input.
- Metamodel 5 (Selfish Brain/Immune): The dorsal horn is a "selfish gate"—it amplifies threat signals to commandeer brain resources (attention, emotion, motor control) for survival. This explains why chronic pain co-occurs with fatigue, cognitive dysfunction, and mood disorders.
- Evolutionary Mismatch: Chronic low-grade inflammation (sedentarism, processed food, social isolation) persistently activates dorsal horn microglia—an immune response designed for acute infection, now maladapted to modern stressors.
Clinical Thresholds:
- Allodynia threshold: Von Frey filament <0.4g in normally non-painful areas indicates dorsal horn sensitization
- Wind-up ratio: >2.0 (pain rating to 10 repeated stimuli / single stimulus) suggests temporal summation from NMDA receptor hyperactivity
- Spinal IL-6: Elevated in CSF (>10 pg/mL) correlates with chronic pain severity
Intervention Implications:
- Spinal injections: Traumeel, lactic acid (pH 3.2-3.8), or PRP directly target dorsal horn inflammation—aim to reduce microglial activation and restore GABA/glycine inhibition
- Systemic anti-inflammatory protocols: Omega-3 fatty acids, curcumin, resolvins reduce peripheral cytokine drive to dorsal horn
- Descending modulation training: Aerobic exercise, meditation, and graded motor imagery activate PAG-RVM descending inhibition
- Pain neuroscience education: Reconceptualizing pain as "overprotective alarm" reduces threat perception, which can modulate descending facilitation
- Avoid opioids for chronic pain: Chronic opioid use paradoxically increases dorsal horn excitability (opioid-induced hyperalgesia via NMDA receptor activation)
Exam-Relevant Clinical Point: The dorsal horn is why non-painful stimuli can trigger pain (allodynia) and painful stimuli hurt more (hyperalgesia) in chronic pain syndromes. This is not "psychological"—it is measurable dorsal horn hyperexcitability, driven by loss of GABAergic inhibition and microglial BDNF release.
- Dorsal horn grey matter divided into Rexed laminae I-VI; laminae I-II (substantia gelatinosa) are nociceptive-specific
- C-fibres release Substance P (11 amino acid neuropeptide) and glutamate at first synapse
- A-delta fibres mediate "first pain" (sharp, localized); C-fibres mediate "second pain" (dull, diffuse)
- NMDA receptor activation requires both glutamate binding AND membrane depolarization (Mg²⁺ block removal)—this is the molecular basis of wind-up
- Substance P acts on NK1 receptors on lamina I projection neurons, causing minutes-long depolarization (vs. glutamate's millisecond activation)
- GABA and glycine are the primary inhibitory neurotransmitters; their loss (via interneuron apoptosis) is sufficient to produce allodynia
- Microglia in dorsal horn express P2X4 receptors; ATP from damaged cells activates them → BDNF release → KCC2 downregulation → GABA becomes excitatory
- Descending serotonin can be both inhibitory (5-HT1A receptors) and facilitatory (5-HT3 receptors)—balance determines net effect
- c-Fos expression in dorsal horn neurons is the gold-standard marker of nociceptive activation in animal models
- Spinal morphine works by activating μ-opioid receptors on presynaptic C-fibre terminals → inhibits Ca²⁺ channels → reduces Substance P release
- spinal cord — dorsal horn constitutes the posterior grey matter of spinal cord segments; organized somatotopically
- C-fibres — unmyelinated nociceptive afferents that synapse in superficial dorsal horn (laminae I-II) and release Substance P
- A-delta fibres — myelinated nociceptive afferents mediating fast "first pain" via dorsal horn laminae I and V projections
- A-beta fibres — large myelinated mechanoreceptors that synapse in laminae III-IV; their activation can "close the gate" via inhibitory interneurons
- dorsal root ganglion — contains cell bodies of all primary sensory neurons that synapse in dorsal horn
- nociceptors — peripheral terminals of sensory neurons whose central terminals synapse in dorsal horn laminae I-II
- Substance P — neuropeptide released by C-fibres in dorsal horn; binds NK1 receptors on second-order neurons to amplify pain transmission
- glutamate — primary fast excitatory neurotransmitter in dorsal horn; activates AMPA (fast) and NMDA (slow, wind-up) receptors
- central sensitization — pathological state of dorsal horn hyperexcitability due to NMDA receptor activation, microglial BDNF release, and loss of GABAergic inhibition
- gate control theory — Melzack & Wall's model proposing that dorsal horn interneurons modulate pain transmission via A-beta fibre-mediated inhibition
- descending pain modulation — PAG-RVM-dorsal horn pathway releasing serotonin, noradrenaline, and enkephalins to suppress nociceptive transmission
- spinothalamic tract — ascending pathway carrying nociceptive signals from dorsal horn laminae I and V to lateral thalamus
- periaqueductal gray — midbrain structure that sends descending inhibitory projections to dorsal horn via RVM
- inflammation — peripheral cytokines (IL-1β, TNF-α) sensitize C-fibres and activate dorsal horn microglia, driving central sensitization
- GABA — inhibitory neurotransmitter in dorsal horn; loss of GABAergic interneurons (via caspase-3 apoptosis) produces allodynia
- enkephalins — endogenous opioid peptides released by descending pathways; activate μ-opioid receptors on C-fibre terminals to inhibit Substance P release
- microglia — resident immune cells in dorsal horn; chronic activation releases BDNF, IL-1β, TNF-α → amplifies pain and impairs GABA inhibition
- allodynia — pain from non-noxious stimuli; caused by dorsal horn sensitization allowing A-beta input to activate nociceptive projection neurons
- hyperalgesia — exaggerated pain response to noxious stimuli; reflects dorsal horn NMDA receptor wind-up and loss of inhibitory tone
- fibromyalgia — chronic widespread pain syndrome characterized by dorsal horn sensitization, elevated Substance P in CSF, and loss of descending inhibition
- chronic pain — sustained pain >3 months; often driven by persistent dorsal horn hyperexcitability independent of ongoing tissue damage
- BDNF — brain-derived neurotrophic factor released by dorsal horn microglia; downregulates KCC2 chloride transporter → impairs GABA/glycine inhibition
- NMDA receptor — glutamate receptor requiring both agonist binding and depolarization for activation; mediates wind-up and long-term potentiation in dorsal horn
- neurogenic inflammation — C-fibre activation causes antidromic release of Substance P and CGRP in periphery, amplifying inflammation that feeds back to dorsal horn
- rostral ventromedial medulla — brainstem nucleus providing both facilitatory (via 5-HT3) and inhibitory (via enkephalins) projections to dorsal horn
- anterior cingulate cortex — receives affective pain signals from dorsal horn via spinoreticular tract and medial thalamus; processes pain unpleasantness
- spinal injection — clinical intervention (Traumeel, lactic acid, PRP) targeting dorsal horn inflammation to reduce microglial activation and restore inhibitory tone
- pain neuroscience education — teaching patients that persistent pain reflects dorsal horn sensitization, not tissue damage—reduces threat appraisal and descending facilitation
- Omega-3 fatty acids — EPA/DHA reduce dorsal horn microglial activation and shift lipid mediators toward pro-resolution (resolvins, protectins)
- exercise — aerobic activity activates PAG-RVM descending inhibition and increases endogenous opioid tone in dorsal horn
- Module 3 (Neuroendocrinology and immune system interaction)
- Module 5 (Pain mechanisms and modulation)
- Module 11 (Clinical applications and intervention strategies)